MARKET

ACST

ACST

Acasti Pharma Inc
NASDAQ
0.4340
+0.0029
+0.67%
After Hours: 0.4400 +0.006 +1.38% 19:22 03/29 EDT
OPEN
0.4301
PREV CLOSE
0.4311
HIGH
0.4500
LOW
0.4100
VOLUME
55.49K
TURNOVER
0
52 WEEK HIGH
1.350
52 WEEK LOW
0.3400
MARKET CAP
19.36M
P/E (TTM)
-1.0695
1D
5D
1M
3M
1Y
5Y
BRIEF-Acasti Pharma Inc. Centralizes Marketplace For Shares On The Nasdaq With Voluntary Delisting From TSX Venture Exchange
Reuters · 03/13 12:14
EF Hutton Remains a Buy on Acasti Pharma (ACST)
TipRanks · 02/15 12:25
EF Hutton Reiterates Buy on Acasti Pharma, Maintains $2.5 Price Target
Benzinga · 02/15 12:02
BRIEF-Acasti Pharma Reports Third Quarter 2023 Operational Results
Reuters · 02/14 12:52
Acasti Pharma Q3 EPS $(0.09) Beats $(0.11) Estimate, Cash Balance Of $31.3M With Cash Runway Into Q2 Of 2024
Benzinga · 02/14 12:04
Acasti Pharma GAAP EPS of -$0.09
Seeking Alpha · 02/14 12:03
Acasti Pharma's Earnings Outlook
Benzinga · 02/13 14:01
Acasti Receives Extension To Regain Compliance With NASDAQ Minimum Bid Price Rule
Benzinga · 01/25 14:02
More
About ACST
Acasti Pharma Inc. is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: Subarachnoid Hemorrhage (SAH), Ataxia Telangiectasia (A-T), and Postherpetic Neuralgia (PHN). The Company's lead product candidate includes GTX-104, which is a clinical-stage nanoparticle formulation of nimodipine being developed for IV infusion in SAH patients. The Company's other pipeline products include GTX-102, an oral mucosal spray formulation of betamethasone intended to develop neurological symptoms of A-T, including developing clinical assessments of posture and gait disturbance, and kinetic speech and oculomotor functions. GTX-101 is a topical bio-adhesive film-forming spray of bupivacaine for the treatment of PHN.

Webull offers kinds of Acasti Pharma Inc stock information, including NASDAQ:ACST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACST stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACST stock methods without spending real money on the virtual paper trading platform.